We are live on
!
Find out more
CCP
Cryder Capital Partners Portfolio holdings
AUM
$1.53B
1-Year Est. Return
9.36%
This Fund
S&P 500
This Quarter
Est. Return
+8.17%
1 Year Est. Return
+9.36%
3 Year Est. Return
+71.2%
5 Year Est. Return
+84.02%
10 Year Est. Return
+425.03%
AUM
$273M
AUM Growth
+$26.2M
(+11%)
Cap. Flow
+$2.86M
Cap. Flow
% of AUM
1.05%
Top 10 Holdings %
Top 10 Hldgs %
94.33%
Holding
12
New
1
Increased
1
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$15.3M |
| 2 |
IQVIA
IQV
|
+$28.4K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRXL
Parexel International Corp
PRXL
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.5% |
| 2 | Financials | 30.46% |
| 3 | Communication Services | 25.17% |
| 4 | Technology | 11.87% |
Similar funds
HR
SG
FBB
FI
MCP
CCM
AF
ICM
Cryder Capital Partners's Q2 2017 Portfolio in Review
As of Q2 2017, Cryder Capital Partners held 12 positions worth $273M, up 11% from $247M the previous quarter. Its ten largest holdings account for 94% of the portfolio.
Cryder Capital Partners's Q2 2017 filing shows 1 new, 1 increased and 1 closed positions. Its largest new stake was PayPal: 310,385 shares worth $16.7M. The largest sale was Parexel International Corp, an estimated $12.4M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 37% a quarter earlier, followed by Financials and Communication Services.
- Cryder Capital Partners's largest Q2 2017 buy was PayPal: 310,385 shares worth $16.7M.
- Cryder Capital Partners added most to IQVIA in Q2 2017, an estimated $28.4K increase.
- Cryder Capital Partners fully exited Parexel International Corp in Q2 2017, selling an estimated $12.4M.
- Cryder Capital Partners's ten largest holdings make up 94% of its $273M portfolio in Q2 2017.
- Cryder Capital Partners opened 1 new position and closed 1 in Q2 2017.
- Cryder Capital Partners's portfolio value rose 11% quarter-over-quarter to $273M.
Based on Cryder Capital Partners's 13F filing for Q2 2017, filed 27 Jul 2017.